Randi G, Altieri A, Gallus S, Franceschi S, Negri E, Talamini R, La Vecchia C
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Ann Oncol. 2005 Sep;16(9):1551-5. doi: 10.1093/annonc/mdi266. Epub 2005 May 26.
Cirrhosis is strongly related to liver cancer. Data on the possible association between cirrhosis and risk at other cancer sites are scanty.
We analysed data from a network of case-control studies conducted in Italy between 1983 and 1997, including patients with cancers of the oral cavity and pharynx (520), oesophagus (405), stomach (731), colon (943), rectum (613), liver (425), gallbladder (63) and pancreas (395). The controls were 4297 patients admitted to hospitals for acute non-neoplastic conditions.
After strict allowance for alcohol drinking, tobacco smoking and history of hepatitis, the multivariate odds ratios for a history of cirrhosis were 4.7 [95% confidence interval (CI) 2.2-9.8] for neoplasms of the oral cavity and pharynx, 2.6 (95% CI 1.2-5.7) for the oesophagus, 1.0 (95% CI 0.4-2.5) for the stomach, 1.0 (95% CI 0.4-2.4) for the colon, 1.7 (95% CI 0.7-4.1) for the rectum, 20.5 (95% CI 12.3-34.2) for the liver, 2.1 (95% CI 0.3-16.8) for the gallbladder and 0.9 (95% CI 0.3-3.0) for the pancreas.
Our study confirms and further quantifies the increased risk of liver cancer in cirrhotic patients and is compatible with an increased risk of oral, pharyngeal and oesophageal cancers.
肝硬化与肝癌密切相关。关于肝硬化与其他癌症部位风险之间可能存在的关联的数据较少。
我们分析了1983年至1997年在意大利进行的一项病例对照研究网络的数据,包括口腔和咽癌患者(520例)、食管癌患者(405例)、胃癌患者(731例)、结肠癌患者(943例)、直肠癌患者(613例)、肝癌患者(425例)、胆囊癌患者(63例)和胰腺癌患者(395例)。对照组为4297名因急性非肿瘤性疾病入院的患者。
在严格考虑饮酒、吸烟和肝炎病史后,肝硬化病史的多因素优势比在口腔和咽肿瘤中为4.7[95%置信区间(CI)2.2 - 9.8],食管癌中为2.6(95%CI 1.2 - 5.7),胃癌中为1.0(95%CI 0.4 - 2.5),结肠癌中为1.0(95%CI 0.4 - 2.4),直肠癌中为1.7(95%CI 0.7 - 4.1),肝癌中为20.5(95%CI 12.3 - 34.2),胆囊癌中为2.1(95%CI 0.3 - 16.8),胰腺癌中为0.9(95%CI 0.3 - 3.0)。
我们的研究证实并进一步量化了肝硬化患者患肝癌风险的增加,并且与口腔、咽和食管癌风险增加相符。